TRCT
PILL

Tower Research Capital (TRC)’s Direxion Daily Pharmaceutical & Medical Bull 2X Shares PILL Stock Holding History

Tower Research Capital (TRC)’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$2K – 3991
2017
Q1 		$2K Buy
+100
New +$2.37K ﹤0.01% 2740

Tower Research Capital (TRC)'s PILL Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of Direxion Daily Pharmaceutical & Medical Bull 2X Shares (PILL) in Q2 2017, closing a stake of 100 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in PILL in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 0 funds tracked by Wall St. Rank hold PILL as of Q2 2017.

  • Tower Research Capital (TRC) reported no remaining Direxion Daily Pharmaceutical & Medical Bull 2X Shares position as of Q2 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 Direxion Daily Pharmaceutical & Medical Bull 2X Shares shares in Q2 2017, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in Direxion Daily Pharmaceutical & Medical Bull 2X Shares in Q1 2017 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Direxion Daily Pharmaceutical & Medical Bull 2X Shares position peaked at $2K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 2X Shares as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.